Click here to RETURN to the previous page

Factor Ten: Femtrac

Hormone Replacement Myths

Factor Ten: Femtrac is synergistically balanced to supply the phytoestrogens and other dietary nutrients that complement the three rhythmic patterns of change that a woman's reproductive system follow throughout her adult life.  This product provides both pre-menstrual (PMS) and Premenstrual Dysphoric Disorder (PMDD) relief and the amelioration of symptoms that arise during perimenopause (transition) and menopause cessation of menses.

Premenstrual Syndrome (PMS) & Premenstrual Dysphoric Disorder (PMDD)…

…is a common hormone related condition, which typically commences ten days prior to menses and resolves with the start of menstruation.  It is most prevalent between the ages of 30 and 45 who may experience a variety of recurrent symptoms, including lethargy, depression, mood swings, cramping, breast tenderness and bloating.  The major cause of this condition is poor dietary habits, lack of proper nutrition and insufficient exercise.  Essentially, it is a lifestyle-related ailment.


…is the transition period from regular ovulatory cycles to menopause that usually begins at the age of 43 approximately five to seven years before a woman's final menses.  As estrogen levels begin to decrease in anticipation of menopause, many women experience weight gain.  Collagen production also drops with subsequent decrease in skin elasticity and dryness of mucosal surfaces.  These conditions are normal occurrences until hormonal balance has been achieved following perimenopause.


…the cessation of menses, is defined as the absence of menstrual bleeding due to loss of ovarian function.  The physical changes of menopause arise from hormonal changes, which may reproduce symptoms of vasomotor instability such as hot flashes, night sweats, palpitations and headaches until hormone levels stabilize themselves.  It is a natural part of a woman's aging process and usually begins at age 50.  In short, It is a stage of life, perhaps complicated by poor lifestyle choices, but it is not a disease.

Three Hormone Replacement Myths

Myth 1: Osteoporosis is an estrogen deficiency disease

An absolute NO!  Osteoporosis begins a decade or more before estrogen levels fall and accelerates for a few years at menopause.  While taking estrogen can slow bone loss, its effect wears off within a few years following menopause. It is excess protein in the form of meat and dairy products that contribute the most to bone loss, an acidic condition is created in the blood and the body pulls out calcium from the bones to neutralize it.  The current high protein diet fad that many are on is going to exacerbate this problem! The Factor Ten: Femtrac formulation includes the herbal extract Centella asiatica which increases the formation of chondroitin sulfate in bone tissue.1

Myth 2: Progesterone prevents female cancers

Progesterone protects against female cancers in those cases where women are taking estrogen.  "Phytoestrogens” have been used for thousands in other countries and do not seem to be linked in increased rates of breast or endometrial cancer, which are known risks of estrogen therapy,” states nutritional scientist Dr Shari Lieberman.2

Myth 3: Estrogen prevents cardiovascular disease

Ample evidence exists showing that the opposite is true!  Research reveals that high doses of estrogens are likely to be thrombogenic (blood clotting) and cause hypercoagulabiity, thereby increasing the risk of heart attack and stroke.  Estrogen further compromises the integrity and function of cell membranes by allowing the loss of potassium and magnesium.  Factor Ten: Femtrac supplies the necessary dosage of these twin minerals necessary for smooth heart function.

The Hormone Replacement (HRT) Fad

The current fad of prescribing synthetic estrogens and progestins onto menopausal women may prove to be one of the biggest medical blunders of the 20th century.  Synthetic estrogen side effects include abnormal vaginal bleeding, weight gain, peripheral edema and increased risk of endometrial (uterus) and breast cancers.3  Adverse effects of progestin (synthetic progesterone) include acne, decreased libido, lethargy, anxiety and menstrual bleeding.4

Undergoing HRT has been compared to taking an addictive drug.5  Clinical studies show that severe withdrawal symptoms often accompany women who have stopped HRT after having received long-term treatment.  Pharmaceutical misinformation may be making estrogen addicts out women.

The Hormone Foundation, a Washington, D.C. based nonprofit health organization, released a consensus statement supporting alternative to hormone replacement therapy at the 80th annual (1998) Endocrine Society Meeting in New Orleans.

Final Thought

The natural design of a woman's body is to produce the two hormones, estrogen and progesterone, in very sensitive and precise balances so reproductive ability is maximized.  Estrogen fulfills its role of preparing the endometrium for pregnancy while progesterone is necessary for survival of the fertilized ovum, the resulting embryo and the fetus.  Once a woman is past her childbearing years, her need for both these hormones is minimal.

The perception of menopause as a life period of undesirable symptoms and regressive illness due to estrogen deficiency is not supported by fact nor clinic studies, states Dr. Jerilyn Prior, researcher and Professor of Endocrinology at the University of British Columbia.

Factor Ten: Femtrac is a synergistically balanced, high bioavailable, ALL natural encapsulated woman's supplement.  It was specifically formulated for those women who cherish the daily rejuvenation of the body's vital substances throughout the hormonal changes that a woman's body follows during her adult life.


  1. Continuing Education, American Druggist, November 1999.
  2. Beckman, N. Menopause : A Positive Approach Using Natural Therapies.  Australia: Penguin Books, 1995.
  3. British Medical Bulletin, vol 48, pp. 458-68, 1992.
  4. Lawrence, JC, J Investigative Dermatol, vol 49, pp 95-6, 1967.
  5. Herbs Help Treat Menopausal Symptoms, conference on Women’s Health, Washington, DC, 1998.